Mirati TherapeuticsMRTX
13F holders, Q1 2024 (March 31)2holders
$58.72avg. 13F price*
At the end of Q1 2024, 2 institutions reported holding Mirati Therapeutics Inc. (MRTX) in their 13F filings. The largest holders were Sachetta, LLC ($1K) and IFP Advisors, Inc ($1K).
- Company
- Mirati Therapeutics Inc.
- CUSIP
- 60468T105
- Latest filing quarter
- Q1 2024
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 213 | $4.5B |
Ownership 2 holders
| Sachetta, LLC | 0.00% | No change | 24 | $1K |
| IFP Advisors, Inc | 0.00% | Reduce -99.5% | 19 | $1K |
"% of holder's portfolio" is MRTX's weight in each manager's 13F, not the share of Mirati Therapeutics Inc. the manager owns.